Annette Wanki, | |
1939 Mortar Loop Apt A, Newport News, VA 23603-1502 | |
(240) 305-5767 | |
Not Available |
Full Name | Annette Wanki |
---|---|
Gender | Female |
Speciality | In Home Supportive Care |
Location | 1939 Mortar Loop Apt A, Newport News, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306453949 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Annette Wanki, 5228 Verenda Ave, Twentynine Palms, CA 92277-1780 Ph: (240) 305-5767 | Annette Wanki, 1939 Mortar Loop Apt A, Newport News, VA 23603-1502 Ph: (240) 305-5767 |
News Archive
The Baltimore Sun reports: "[P]harmaceutical companies that make … prescription drugs are also looking over the doctor's shoulder, keeping track of how many prescriptions for whose drugs the individual physician is writing."
Octavio Ramilo, MD, chief of Infectious Diseases at Nationwide Children's Hospital, is one of three principal investigators who will share in a five-year, $3.4 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dr. Ramilo and a team of more than 50 physicians across the United States are investigating the use of novel technologies for distinguishing between bacterial and viral infections in infants with fevers within emergency departments.
For older patients with acute myeloid leukemia, the prospects for success of a stem cell transplant can often be predicted based on the particular set of genetic mutations within the tumor cells, investigators at Dana-Farber Cancer Institute and other research centers will report today at the 61st American Society of Hematology (ASH) Annual Meeting.
BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today that a blinded, multi-center clinical study of the CellDetect non-invasive test for detecting bladder cancer in urine, successfully achieved the study's primary endpoint for effectively detecting the recurrence of bladder cancer in subjects with a history of the disease.
› Verified 1 days ago